SCHEMBL28550543

SCHEMBL28550543

CCC(C(=O)NCCCC(=O)OC)N1CCCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA3 P07451 1/20 0.53
▸ CA4 P22748 1/20 0.53
▸ CA6 P23280 1/20 0.53
▸ CA5A P35218 1/20 0.53
▸ CA7 P43166 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ CA13 Q8N1Q1 1/20 0.53
▸ CA14 Q9ULX7 1/20 0.53
▸ CA5B Q9Y2D0 1/20 0.53
▸ EPHX2 P34913 5/20 0.38
▸ GAA P10253 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28911880 0.88 LMNA (0.63) LMNACA12CA1CA2CA3
SCHEMBL28911906 0.84 LMNA (0.55) LMNACA12CA1CA2CA3
SCHEMBL3980474 0.80 LMNA (0.58) LMNACA12CA1CA2CA3
Etiracetam SCHEMBL28554623 0.79 LMNA (0.74) LMNACA12CA1CA2CA3
SCHEMBL11513671 0.78 LMNA (0.56) LMNACA12CA1CA2CA3
SCHEMBL11348543 0.78 LMNA (0.49) LMNACA12CA1CA2CA3
SCHEMBL14367750 0.77 LMNA (0.61) LMNACA12CA1CA2CA3
SCHEMBL1880935 0.76 LMNA (0.69) LMNACA12CA1CA2CA3
SCHEMBL12106667 0.76 LMNA (0.69) LMNACA12CA1CA2CA3
SCHEMBL15838651 0.76 LMNA (0.69) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724061-A Levetiracetam impurity PBBA and preparation method thereof 浙江华海药业股份有限公司 2021-04-30 — — CN claimed
CN-112724061-A Levetiracetam impurity PBBA and preparation method thereof 浙江华海药业股份有限公司 2021-04-30 — — CN disclosed
Send feedback